Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding

Dysfunctional Voiding Clinical Trial

Official title:

The Effect of Dynamic Neuromuscular Stabilization Training in Dysfunctional Voiding : A Randomized Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06040333
• Other study ID #: ssaka8
• Status: Completed
• Phase: N/A
• Start date: March 2, 2021
• Est. completion date: June 21, 2023

Study information

• Verified date: September 2023
• Source: Halic University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Uroflowmetry, Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form were applied to all participants at baseline and at week 6.

Description:

In this study, the effect of dynamic neuromuscular stabilization (DNS) exercise on urinary flow and quality of life in individuals with dysfunctional voiding was investigated. This experimental study was conducted with patients who applied to UroKlinik in Istanbul between March 2021 and June 2023 and were diagnosed with dysfunctional voiding. The 34 participants included in the study were randomized into two groups: the experiment in which DNS exercises were applied and the standard therapy group in which the manual application was applied. Voiding Symptom Score (DVSS), Short Form-36 Quality of Life Assessment Short Form and Uroflowmetry test were applied to all participants before and at week 6.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: June 21, 2023
• Est. primary completion date: April 7, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Having been diagnosed with dysfunctional voiding,
• Being between the ages of 18-75,
• Not having a neurogenic bladder
• Not having a urinary tract infection
• Not having an obstacle to exercise,
• Accepting and signing the Approval Form,
• Not having undergone surgery in the last 6 months,

Exclusion Criteria:

• Not being cooperative
• Not being able to participate in the treatment,
• The use of drugs that will affect urination

Related Conditions & MeSH terms

• Dysfunctional Voiding

Intervention

Other:
• Exercise
Dynamic Neuromuscular Stabilisation Exercise
• Standard therapy
Patient education, massage, diaphragmatic breathing, kegel exercise

Locations

Country	Name	City	State
Turkey	Haliç University	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Halic University

Country where clinical trial is conducted

Turkey, 

References & Publications (6)

Akbal C, Genc Y, Burgu B, Ozden E, Tekgul S. Dysfunctional voiding and incontinence scoring system: quantitative evaluation of incontinence symptoms in pediatric population. J Urol. 2005 Mar;173(3):969-73. doi: 10.1097/01.ju.0000152183.91888.f6. — View Citation

Altunkol A, Abat D, Sener NC, Gulum M, Ciftci H, Savas M, Yeni E. Is urotherapy alone as effective as a combination of urotherapy and biofeedback in children with dysfunctional voiding? Int Braz J Urol. 2018 Sep-Oct;44(5):987-995. doi: 10.1590/S1677-5538. — View Citation

Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, Rittig S, Walle JV, von Gontard A, Wright A, Yang SS, Neveus T. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardizat — View Citation

Haylen BT, Ashby D, Sutherst JR, Frazer MI, West CR. Maximum and average urine flow rates in normal male and female populations--the Liverpool nomograms. Br J Urol. 1989 Jul;64(1):30-8. doi: 10.1111/j.1464-410x.1989.tb05518.x. — View Citation

Mahdieh L, Zolaktaf V, Karimi MT. Effects of dynamic neuromuscular stabilization (DNS) training on functional movements. Hum Mov Sci. 2020 Apr;70:102568. doi: 10.1016/j.humov.2019.102568. Epub 2020 Jan 13. — View Citation

Zivkovic V, Lazovic M, Vlajkovic M, Slavkovic A, Dimitrijevic L, Stankovic I, Vacic N. Diaphragmatic breathing exercises and pelvic floor retraining in children with dysfunctional voiding. Eur J Phys Rehabil Med. 2012 Sep;48(3):413-21. Epub 2012 Jun 5. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Uroflowmetry - Maximum flow rate (Qmax)	Uroflowmetry gives information about urine flow rate and voiding pattern.; *Qmax (mL/s): Qmax is the fastest stream measured in mL/s.	at the baseline and at week 6.
Primary	Uroflowmetry - Average flow rate (Qave)	Uroflowmetry gives information about urine flow rate and voiding pattern.; *Qave (mL/s): Qave is the average stream measured in mL/s.	at the baseline and at week 6.
Primary	Uroflowmetry - Corrected maximum flow rate (cQmax)	Uroflowmetry gives information about urine flow rate and voiding pattern.; *cQmax (mL/s/v mL): cQmax is the precise assessment of fastest stream, especially at high volumes. Is it estimated Qmax/v VV.	at the baseline and at week 6.
Primary	Uroflowmetry - Flow time (FT)	Uroflowmetry gives information about urine flow rate and voiding pattern.; *FT (s): FT is the time over which measurable flow actually occurs.	at the baseline and at week 6.
Primary	Uroflowmetry - Voiding volume (VV)	Uroflowmetry gives information about urine flow rate and voiding pattern.; *VV (ml): VV indicates the amount of voiding.	at the baseline and at week 6.
Primary	Uroflowmetry - Residual urine (RU)	Uroflowmetry gives information about urine flow rate and voiding pattern.; *RU (ml): RU is the amount of urine that is left behind in the bladder after you are done urinating.	at the baseline and at week 6.
Primary	Dysfunctional Voiding and Incontinence Symptom Score	It gives information about voiding and incontinence symptoms. The questionnaire contains fourteen questions about symptoms and quality of life. The total score ranges from 0 to 35 and a score above 8.5 indicates abnormalities.	at the baseline and at week 6.
Primary	Short Form 36	It gives information about health related quality of life. The total score of the scale ranges from 0 to 100, and a high score indicates a high quality of life.	at the baseline and at week 6.